SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
SGNT was delisted on the 29th of August, 2016.
127 hedge funds and large institutions have $577M invested in SAGENT PHARMACEUTICALS INC COM STK (DE) in 2015 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 55 increasing their positions, 43 reducing their positions, and 21 closing their positions.
28% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 43
3% less funds holding
Funds holding: 131 → 127 (-4)
6% less capital invested
Capital invested by funds: $616M → $577M (-$39.1M)
14% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 21
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$18M |
| 2 |
PCM
Penn Capital Management
Philadelphia,
Pennsylvania
|
+$13M |
| 3 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$8.9M |
| 4 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
+$8.58M |
| 5 |
AGA
Altrinsic Global Advisors
Stamford,
Connecticut
|
+$6.26M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$53.1M |
| 2 |
NIMC
NWQ Investment Management Company
Los Angeles,
California
|
-$12M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$11.2M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$6.67M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$5.62M |
SGNT Hedge Fund Activity: Q1 2015 in Review
127 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) for Q1 2015, worth a combined $577M — down 6.3% from $616M a quarter earlier.
Sellers outnumbered buyers: 21 funds closed out of SGNT and 18 opened new positions — a net loss of 3 holders — while 43 trimmed existing stakes and 55 added.
The largest buyer was Pictet Asset Management (UK), adding an estimated $18M. The largest seller was Morgan Stanley, cutting an estimated $53.1M.
- 127 institutional investors held SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) as of Q1 2015, down from 131 in Q4 2014.
- Funds reported $577M of SAGENT PHARMACEUTICALS INC COM STK (DE) stock for Q1 2015, down 6.3% quarter-over-quarter.
- 18 funds opened new SAGENT PHARMACEUTICALS INC COM STK (DE) positions in Q1 2015 and 21 closed out, a net change of -3 holders.
- The largest SAGENT PHARMACEUTICALS INC COM STK (DE) buyer in Q1 2015 was Pictet Asset Management (UK), an estimated $18M added.
- The largest SAGENT PHARMACEUTICALS INC COM STK (DE) seller in Q1 2015 was Morgan Stanley, an estimated $53.1M sold.
Based on aggregated 13F filings for Q1 2015.